Login / Signup
Chengfeng Xue
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Drug Delivery
Cancer Therapy
Escherichia Coli
Poor Prognosis
Top Venues
Biotechnology and bioengineering
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Chengfeng Xue
,
I-Son Ng
A direct enzymatic evaluation platform (DEEP) to fine-tuning pyridoxal 5'-phosphate-dependent proteins for cadaverine production.
Biotechnology and bioengineering
120 (1) (2022)